TY - JOUR
T1 - Pharmacists’ role in opioid overdose
T2 - Kentucky pharmacists’ willingness to participate in naloxone dispensing
AU - Freeman, Patricia R.
AU - Goodin, Amie
AU - Troske, Su Zanne
AU - Strahl, Audra
AU - Fallin, Amanda
AU - Green, Traci C.
N1 - Publisher Copyright:
© 2017 American Pharmacists Association®
PY - 2017/4/1
Y1 - 2017/4/1
N2 - Objectives To assess pharmacists’ willingness to initiate the dispensing of naloxone. As of 2015, Kentucky law permits certified pharmacists to dispense naloxone under a physician-approved protocol. Design Electronic survey (e-mail) gauging perception of pharmacists’ role in opioid overdose and attitudes toward, and barriers to, naloxone dispensing. Setting and participants All Kentucky pharmacists with active licenses in 2015. Main outcome measures Ordinal logistic regression was used to estimate the impact of pharmacist characteristics and attitudes on willingness to initiate naloxone dispensing, where the dependent variable was operationalized as a Likert-type question on a scale of 1 (not at all willing) to 6 (very willing). Results Of 4699 practicing Kentucky pharmacists, 1282 responded, of which 834 were community practitioners (response rate 27.3%). Pharmacists reported varying willingness to initiate naloxone dispensing, with 37.3% very willing (score 5 or 6) and 27.9% not willing (score 1 or 2). However, a majority of pharmacists reported willingness to dispense naloxone with a valid prescription (54.0%, score 5 or 6). Women pharmacists were 1.3 times more likely than men to be willing to initiate naloxone dispensing (95% confidence interval [CI] 1.0-1.6). Those who reported confidence in identifying individuals at risk for overdose were 1.2 times more likely to initiate dispensing, and those who reported confidence in ability to educate patients about overdose were 1.6 times more likely to express willingness to initiate naloxone dispensing (95% CIs, respectively, 1.0-1.3 and 1.4-1.8). Community pharmacists reported barriers to naloxone access at higher rates than pharmacists from other practice settings. Conclusion Kentucky pharmacists are divided in their willingness to initiate naloxone dispensing; however, those who are confident in their ability to identify overdose risks are more willing. Increasing pharmacist confidence through appropriately designed education programs could facilitate pharmacist participation in naloxone dispensing.
AB - Objectives To assess pharmacists’ willingness to initiate the dispensing of naloxone. As of 2015, Kentucky law permits certified pharmacists to dispense naloxone under a physician-approved protocol. Design Electronic survey (e-mail) gauging perception of pharmacists’ role in opioid overdose and attitudes toward, and barriers to, naloxone dispensing. Setting and participants All Kentucky pharmacists with active licenses in 2015. Main outcome measures Ordinal logistic regression was used to estimate the impact of pharmacist characteristics and attitudes on willingness to initiate naloxone dispensing, where the dependent variable was operationalized as a Likert-type question on a scale of 1 (not at all willing) to 6 (very willing). Results Of 4699 practicing Kentucky pharmacists, 1282 responded, of which 834 were community practitioners (response rate 27.3%). Pharmacists reported varying willingness to initiate naloxone dispensing, with 37.3% very willing (score 5 or 6) and 27.9% not willing (score 1 or 2). However, a majority of pharmacists reported willingness to dispense naloxone with a valid prescription (54.0%, score 5 or 6). Women pharmacists were 1.3 times more likely than men to be willing to initiate naloxone dispensing (95% confidence interval [CI] 1.0-1.6). Those who reported confidence in identifying individuals at risk for overdose were 1.2 times more likely to initiate dispensing, and those who reported confidence in ability to educate patients about overdose were 1.6 times more likely to express willingness to initiate naloxone dispensing (95% CIs, respectively, 1.0-1.3 and 1.4-1.8). Community pharmacists reported barriers to naloxone access at higher rates than pharmacists from other practice settings. Conclusion Kentucky pharmacists are divided in their willingness to initiate naloxone dispensing; however, those who are confident in their ability to identify overdose risks are more willing. Increasing pharmacist confidence through appropriately designed education programs could facilitate pharmacist participation in naloxone dispensing.
UR - http://www.scopus.com/inward/record.url?scp=85019083622&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85019083622&partnerID=8YFLogxK
U2 - 10.1016/j.japh.2016.12.064
DO - 10.1016/j.japh.2016.12.064
M3 - Article
C2 - 28139459
AN - SCOPUS:85019083622
SN - 1544-3191
VL - 57
SP - S28-S33
JO - Journal of the American Pharmacists Association
JF - Journal of the American Pharmacists Association
IS - 2
ER -